HOOKIPA announces strategic collaboration and license agreement

VIP LIVEALERTS-PRO HOOKIPA strategic collaboration HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers Roche to receive license for HOOKIPA’s HB-700 program and option to license a second undisclosed novel arenaviral immunotherapy HOOKIPA to receive $25 million in upfront cash as well as potential future success-based milestone […]